J&J’s Psoriasis Pill Clears Skin in 70% of Patients at 2 Years
Johnson & Johnson’s Psoriasis Pill ICOTYDE® Sustains Skin Clearance in 70% of Patients Over Two Years In a significant advancement for dermatology, Johnson & Johnson (NYSE: JNJ) has released two-year…
